Advertisement
  • Healthy Habits

    Losing It

    Shed weight with a healthy diet to cut your risk.

    by Alanna Kennedy-Gorman

  • Clinical Trials Game-Changer?

    A new type of clinical trial aims to identify which drug is the best fit for each patient's tumor. Can this innovative model expedite new drug approvals?

    by Sue Rochman

  • Cancer In America

    Standard of Care

    Research suggests that black patients, as a whole, aren't receiving the same level of treatment as white patients. Can building better bonds between doctors and patients help?

    by Charlotte Huff

  • The HPV Cancer Connection: Take 2

    New insights about HPV's role in multiple cancers are rapidly expanding, as are thoughts about who should be vaccinated against the virus, and why.

    by Alanna Kennedy-Gorman

  • Healthy Habits

    Just Another Meatless Monday

    Make room for tasty vegetarian dishes in your weekly menu.

    by Alanna Kennedy-Gorman

  • Forward Look

    Cancer Screening: A Dose of Reality

    Q&A with H. Gilbert Welch, professor of medicine at the Dartmouth Institute for Health Policy and Clinical Practice.

    by Sue Rochman

  • Forward Look

    When Is “Cancer” Not Cancer?

    Does the word “cancer” discourage patients with very early disease from fully considering all their options?

    by Stephen Ornes

  • Forward Look

    The Avastin Roller Coaster

    Ups and downs keep coming for Avastin as studies report on its effects for different cancers.

    by Sue Rochman

  • Forward Look

    Boosting Defenses Against Cancer

    Q&A with immunologist James P. Allison, Memorial Sloan-Kettering Cancer Center, New York City.

    by Ingfei Chen

  • Forward Look

    Second-Cancer Clues?

    Genetic marker discovery could help childhood Hodgkin survivors assess risks associated with radiation.

    by Mitzi Baker